Jon M. Foster - Feb 13, 2025 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role: EVP and COO
Signature: /s/ Natalie Harrison Cline, Attorney-in-Fact
Stock symbol: HCA
Transactions as of: Feb 13, 2025
Transactions value $: -$220,193
Form type: 4
Date filed: 2/18/2025, 07:33 PM
Previous filing: Jan 30, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HCA	Common Stock	Award	$0	+2.75K	+10.47%	$0.00	29K	Feb 13, 2025	Direct	F1
transaction	HCA	Common Stock	Tax liability	-$220K	-684	-2.36%	$321.92	28.3K	Feb 13, 2025	Direct
holding	HCA	Common Stock						66.5K	Feb 13, 2025	By JMF Trust (Spouse and Robert Nagel, Co-Trustees)
holding	HCA	Common Stock						54.3K	Feb 13, 2025	By LCF Trust (Reporting Person, Trustee)
holding	HCA	Common Stock						18K	Feb 13, 2025	By Spouse

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On January 28, 2022, the reporting person was granted 5,300 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2022-2024. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2022-2024 earnings per share, the number of performance share units that vested equaled 51.9% of the units granted.

Content

On January 28, 2022, the reporting person was granted 5,300 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2022-2024. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2022-2024 earnings per share, the number of performance share units that vested equaled 51.9% of the units granted.